Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hassin-Baer, S.
Right arrow Articles by Michaelson, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hassin-Baer, S.
Right arrow Articles by Michaelson, D. M.
NEUROLOGY 1992;42:551
© 1992 American Academy of Neurology

Antibodies from Down's syndrome patients bind to the same cholinergic neurofilament protein recognized by Alzheimer's disease antibodies

S. Hassin-Baer, MD, E. Wertman, MD, M. Raphael, MD, V. Stark, MD, J. Chapman, MD, PhD and D. M. Michaelson, PhD

Department of Biochemistry, The George S. Wise Faculty of Lift Sciences, Tel Aviv University, Ramat Aviv, Israel (Drs. Hassin-Baer, Chapman, and Michaelson)
Department of Neurogeriatrics, Ezrat Nashim Hospital, Jerusalem, Israel (Drs. Wertman and Raphael)
Ministry of Labour and Social Welfare, Jerusalem, Israel (Dr. Stark).

Down's syndrome (DS) patients who survive beyond the third decade develop brain lesions characteristic of Alzheimer's disease (AD). Sera of AD patients contain antibodies that bind specifically to the heavy neurofilament protein (NF-H) of Torpedo cholinergic neurons. In the present report, we examined whether the AD-like pathologic changes in DS are associated with the existence of such antibodies. Our findings show that IgG of older DS patients (>30 years) binds to Torpedo cholinergic NF-H more readily than does that of young DS patients (<30 years) and age-matched normal controls. In contrast, the extent of binding of IgG from the young and older DS groups to Torpedo and bovine spinal cords NF-H is similar and equal to that of normal controls. These findings suggest that older DS patients, like AD patients, contain anti-NF-H IgG that binds specifically to epitopes highly enriched in Torpedo cholinergic NF-H.

Address correspondence and reprint requests to Prof. D.M. Michaelson, Department of Biochemistry, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Ramat Aviv 69978, Israel.

Supported in part by grants to D.M.M. from the Fund for Basic Research sponsored by the Israel Academy of Sciences and Humanities (grant no. 51/89), from the Herczeg-Schwartz-Krauthamer Foundation, and from the Esterson Trust.

Received April 11, 1991. Accepted for publication in final form August 6, 1991.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1992 by AAN Enterprises, Inc.